February 1, 2008 (Vol. 28, No. 3)

URL:
http://www.medicineandbiotech.com

Rating:
Strong Points: Well organized, well written, topical
Weak Points: None

Summary:
MedicineandBiotech has important news on a timely subject. The site’s name clearly defines its content and it dazzles with topical information. Biotechnology, of course, is the gateway through which almost all modern medicines are arriving. Covering such a rapidly changing subject is a challenge, but MedicineandBiotech meets it nicely. Headline stories on the site at press time included FDA approval for the first oral HIV integrase inhibitor, a policy report on synthetic genomics (by Craig Venter), hope for an ovarian cancer vaccine, and article on increasing supplies for a pandemic influenza vaccine. The site contains a nicely categorized collection of topics (genomics, stem cells, news, nanotech, science education, and much more). There’s an awful lot to like here and I couldn’t find a single shortcoming. I recommend it to you highly.

Previous articleAbbott Pays $20M for a 10.25% Equity Stake in Ibis Biosciences
Next articleImmunoGen Earns Milestone with Biogen Idec’s IND Filing for Anticancer Agent